| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 13.921 | 28.274 | 326.559 | 860.320 | 365.746 | 499.848 | 385.124 | 398.248 | 841.009 |
| Total Income - EUR | 38 | 13.959 | 25.446 | 326.587 | 863.692 | 364.930 | 502.864 | 385.473 | 347.858 | 673.649 |
| Total Expenses - EUR | 425 | 4.062 | 35.368 | 253.929 | 461.372 | 459.687 | 492.210 | 572.504 | 661.041 | 1.181.221 |
| Gross Profit/Loss - EUR | -387 | 9.898 | -9.922 | 72.658 | 402.320 | -94.757 | 10.654 | -187.031 | -313.183 | -507.573 |
| Net Profit/Loss - EUR | -387 | 9.480 | -10.222 | 69.207 | 392.797 | -99.492 | 7.593 | -192.316 | -317.217 | -507.573 |
| Employees | 0 | 1 | 1 | 6 | 9 | 6 | 8 | 10 | 11 | 19 |
Check the financial reports for the company - Esvida Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 492 | 2.602 | 18.448 | 22.357 | 22.369 | 37.438 | 138.065 | 101.545 | 298.031 | 222.125 |
| Current Assets | 2.939 | 18.384 | 33.720 | 209.039 | 503.394 | 312.839 | 350.334 | 436.020 | 563.189 | 614.169 |
| Inventories | 2.533 | 9.342 | 2.103 | 46.480 | 49.489 | 53.182 | 74.498 | 115.694 | 155.058 | 54.555 |
| Receivables | 360 | 711 | 31.464 | 141.992 | 262.342 | 182.644 | 246.472 | 299.809 | 401.518 | 542.234 |
| Cash | 45 | 8.330 | 153 | 20.567 | 191.563 | 77.013 | 29.364 | 20.517 | 6.613 | 17.380 |
| Shareholders Funds | -342 | 9.142 | -622 | 68.639 | 460.107 | 286.934 | 189.587 | -2.141 | -319.351 | -842.602 |
| Social Capital | 45 | 45 | 657 | 688 | 674 | 1.075 | 2.064 | 2.070 | 2.064 | 2.053 |
| Debts | 3.773 | 11.844 | 52.790 | 162.829 | 65.773 | 63.503 | 299.209 | 540.104 | 1.180.968 | 1.679.290 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Esvida Pharma Srl